All In MedTech

Device Trial Radar · NCT04336618

Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population

Last checked: Nov 19, 2026Latest source record: Dec 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

67

Actual

Start

Aug 3, 2020

Primary completion

Sep 27, 2022

Study completion Sep 27, 2022

Sponsor

Lead sponsor
PerspectumNot on our public-company list
Sponsor type
Industry
First posted
Apr 7, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

  • Liver MultiScanDevice

    The LiverMultiscan is a quick 15 minute, contrast free, non-invasive MRI scan that provides 3 liver metrics

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek their interest in participating in future studiesTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Perspectum Inc.

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.